Introduction
Pulmonary fungus infection is a serious lung disease, particularly among the under-immunized population. In recent years, the incidence of pulmonary fungus infections has increased with the widespread use of broad-spectral antibiotics, sugar-coated hormones, immunosuppressants and the development of medical techniques such as organ transplants and malignant tumours. Traditional Western medicine has some limitations, while combination therapy provides new thinking and methods for pulmonary fungus infections.
II. Western medical knowledge of pulmonary fungus infection
(i) Causes
There are many strains of fungus in the lungs, most common of which are cologne, fungus, invisibility, etc. A high number of pyromococcal infections are associated with the long-term use of broad spectrum antibiotics, central intravenous tubes and extra gastrointestinal nutrients; fungus infections are common among immunosuppressors, such as organ transplants, persons with leukaemia, etc., and are associated with inhalation of estrogens in the air; altoococcal infections are mainly inhaled through the respiratory tract and are susceptible to disease when immune functions are impaired.
(ii) Clinical performance
Patients suffer from different symptoms. A light person may have no symptoms or only a slight cough, cough, etc. Heating, coughing, coughing, coughing, chest pain, breathing difficulties, etc. can occur and can even develop into respiratory failure. Images are presented in a variety of ways, such as chords, placards, holes, etc.
(iii) Western medicine
1. Treatment of anti-fist drugs
– Gender cycin B: is a wide spectrum anti-fluccult drug, but has a large side effect, such as kidney toxicity, heat, cold warfare, etc. The kidney function and electrolyte of patients need to be closely monitored when used.
– Fluconium: It has a relatively good therapeutic effect and relatively light side effects, but not very effective for fungus, etc.
– Ictarconium, Vorteconium: Good antibacterial activity for fungus, etc., but relatively high price, with a possible drug interaction.
2. Support for treatment
Treatment such as oxygen-absorption, nutritional support, etc., is required for patients with more severe conditions in order to maintain their respiratory function and body nutrition. If a patient has a low immune function, if an immunosuppressant is used, the dose of the drug may be adjusted appropriately or the drug may be discontinued.
III. Medical awareness of pulmonary fungus infections
(i) Incidence
In Chinese medicine, pulmonary fungus infections can fall into the category of “cough” “panting” “pulmonary pneumoconiosis”. Much of this is due to a lack of aerobics, heat and humidity, or chronic disease, which causes a loss of pulmonary memory, internality, incendiary heat, and a struggle with evil. The pulmonary pulmonary body is so delicate that it is vulnerable to alien evils, and many patients suffer from a lack of positive and negative health, such as a lack of blood and a lack of health.
(ii) Identification
1. Thermal pulmonary type
It is manifested in heat, cough, yellow thick cough, chest pain, agitation, etc. Teeth red, mossy, pulses.
2. Vague pulmonary fever
It can be seen as low heat, larceny, dry cough, dry throat, etc. Teeth less moss, blood count.
3. Pneumocular impotence
Coughs are weak, air is low, coughs are thin, weary, sweaty, cold. Silly tongue, moss, weak pulse.
IV. CENTRAL WESTERN MEDICAL CONTEXT
(i) The principle of treatment
The general rule is that Chinese and western medicine combines the treatment of pulmonary fungus infections to help the evil. On the basis of Western medicine anti-foulbacterial treatment, the internal environment of the body is adjusted using Chinese medicine, increasing the body ‘ s immunity, reducing the side effects of Western medicine and improving the effectiveness of treatment.
(ii) Specific methods
Acute period
While anti-flucose drugs are used, accelerants, pulmonary anticinants, such as accelerants, are given to accelerant, accelerant and accelerant, i.e. accelerant, acne, orange engraved, acne, acne, acne, acne, acne, accelerant, etc. If the patient has a high fever, the plaster can be added to her mother to clear the heat of the fire. At the same time, co-meditation can be carried out with a combination of heating and coughing.
Mitigation period
In cases where the condition is controlled and the patient is in a state of mitigation, there is a positive deficit. In the case of pulmonary heaters, the pneumatic pneumatics can be nourished by salsin, wheat, mackerel, smallpox, salves, lentils, glycerine, etc.; in the case of pneumatic pulmonary pneumatics, the pneumatic pneumatic pulmonary pulmonary pneumatics may be reduced by six-generous Tongans (polythics, white arts, lysin, lysin, lysin, lysine, half-summer etc.) in order to increase the resilience of the body and prevent recurrence.
3. Advantages of Western and Central medicine
Chinese medicine regulates the immune function of the organism, such as yellow tungsten, party membership, etc., which enhances the immunity of the organism; some antithermal antidotes, such as gold and silver flowers, corrosives, etc., have been found to inhibit fungi in in vitro studies. The combination of Western and Central medicine reduces the pathology, reduces the time and dose of anti-facter drugs and reduces the incidence of their side effects. At the same time, it is possible to improve the health and quality of life of patients through Chinese medicine.
Conclusions
The combination of Western and Central medicine for pulmonary fungus infections is an effective treatment. By taking advantage of the antibacterial effect of Western anti-facter medicine and the advantages of Chinese medicine in helping to correct deviant behaviour and in adjusting the functioning of the organism, it is possible to increase the curing rate of pulmonary fungus infections, reduce complications and improve patient prognosis. However, the current research on the combination of Western and Central medicine for pulmonary fungus infection needs to be further developed and more clinical practice and research is needed to optimize treatment programmes.
